How AbbVie Beat Expectations Again in Q1
Few stocks offer the combination of growth, value, and income that AbbVie (NYSE: ABBV) does. However, investors have been concerned about just how long the drugmaker will be able to continue delivering solid growth.
AbbVie announced its first-quarter results before the market opened on Friday. And the growth streak continued. The big-pharma stock rose less than 1% in early trading today. Here are the highlights from AbbVie's first-quarter update.
Image source: Getty Images.
Source Fool.com
